Cognitive Disorder
20
7
7
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.0%
1 terminated out of 20 trials
90.0%
+3.5% vs benchmark
0%
0 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19
Additional Effects of Immersive vr 360 Degree Videos With Aerobic Exercises on Cognitive Functions in Elderly With Mild Cognitive Impairment
Effects of Video Games and Ball Tossing on Eye Hand Coordination in Elderly With Mild Cognitive Impairment.
Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency
Outcomes of ICT Assistive Technology in RehabiliTAtIoN Pathways
EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER
A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders
Assessment of the Need to Use Short Cognitive Tests for French General Practitioners/Family Doctors
Virtual Reality Training for Inhibitory Control in Neurocognitive Disorders
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment
Sleep Disturbance in MCI: A Study of a Cognitive Behavioural Therapy Digital Intervention
Emotional Regulation, Cognition, Impulsivity and Reward System in Obesity: A Prospective Study of Bariatric Surgery
Neurological Blood-based Biomarkers and Cognitive Disorders in Critically Ill Survivors.
Risk of Developing Dementia and Associated Factors in Patients With Normal Brain FDG PET
Study on Cognitive Impairment of Insomnia Based on MRI
Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
Online Cognitive Rehabilitation of Executive Dysfunction in Nonamnestic MCI
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-D4010 in Healthy Subjects
Thinking, Walking Outcomes by Type of Exercise